{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:06:37Z","timestamp":1762113997900,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,6,17]],"date-time":"2013-06-17T00:00:00Z","timestamp":1371427200000},"content-version":"vor","delay-in-days":533,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.cca.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T02:18:39Z","timestamp":1319077119000},"page":"291-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Development of immunoassays for anti-electronegative LDL autoantibodies and immune complexes"],"prefix":"10.1016","volume":"413","author":[{"given":"Tanize do Espirito Santo","family":"Faulin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine Cavalcanti Maur\u00edcio de","family":"Sena-Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora Bezerra","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine Moura","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulcineia Saes Parra","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.10.004_bb0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Leducq transatlantic network on atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2011.10.004_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/723539","article-title":"Antigen-induced immunomodulation in the pathogenesis of atherosclerosis","volume":"2008","author":"Milioti","year":"2008","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.cca.2011.10.004_bb0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2796.2008.01945.x","article-title":"Autoimmunity in atherosclerosis: a protective response losing control?","volume":"263","author":"Nilsson","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.cca.2011.10.004_bb0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2796.2000.00656.x","article-title":"Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis","volume":"247","author":"Palinski","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.cca.2011.10.004_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.ATV.8.1.79","article-title":"Presence of a modified low density lipoprotein in humans","volume":"8","author":"Avogaro","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.cca.2011.10.004_bb0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbalip.2006.03.020","article-title":"Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array","volume":"1761","author":"Ben\u00edtez","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2011.10.004_bb0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbalip.2009.12.001","article-title":"Electronegative LDL induction of apoptosis in macrophages: involvement of Nrf2","volume":"1801","author":"Pedrosa","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2011.10.004_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.atherosclerosis.2004.11.027","article-title":"Identification of mildly oxidized low-density lipoprotein (electronegative LDL] and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings","volume":"184","author":"Barros","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.10.004_bb0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.clinbiochem.2006.05.002","article-title":"Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes","volume":"39","author":"Oliveira","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2011.10.004_bb0050","first-page":"68","article-title":"Antibodies against charged subfractions of LDLs are associated with disturbed ankle-brachial index and cardiovascular risk factors in a Japanese-Brazilian population with high prevalence of dislipidemias","volume":"2","author":"Siqueira","year":"2007","journal-title":"Int J Atheroscler"},{"key":"10.1016\/j.cca.2011.10.004_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2010.12.028","article-title":"Electronegative low-density lipoprotein: origin and impact on health and disease","volume":"215","author":"Mello","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.10.004_bb0060","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/01.ATV.11.5.1356","article-title":"Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies","volume":"11","author":"Lopes-Virella","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.cca.2011.10.004_bb0065","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.168.3.1041","article-title":"Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation","volume":"168","author":"Griffith","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2011.10.004_bb0070","first-page":"1769","article-title":"Validation of a novel ELISA for measurement of electronegative LDL","volume":"46","author":"Faulin","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2011.10.004_bb0075","series-title":"Handbook of experimental immunology","first-page":"2","article-title":"Preparation and purification of active fragments from mouse monoclonal antibodies","author":"Parham","year":"1986"},{"key":"10.1016\/j.cca.2011.10.004_bb0080","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.cca.2011.10.004_bb0085","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/nprot.2006.288","article-title":"Silver staining of proteins in polyacrylamide gels","volume":"1","author":"Chevallet","year":"2006","journal-title":"Nat Protoc"},{"year":"1998","series-title":"The fitness for purpose of analytical methods. A laboratory guide to method validation and related topics","author":"EURACHEM","key":"10.1016\/j.cca.2011.10.004_bb0090"},{"year":"2003","series-title":"Orienta\u00e7\u00f5es sobre valida\u00e7\u00e3o de m\u00e9todos de ensaios qu\u00edmicos","author":"INMETRO DOQ-CGCRE-008","key":"10.1016\/j.cca.2011.10.004_bb0095"},{"key":"10.1016\/j.cca.2011.10.004_bb0100","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation\u2014a revisit with a decade of progress","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.cca.2011.10.004_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2004.05.021","article-title":"Antibodies to oxidized LDL in atherosclerosis development-clinical and animal studies","volume":"348","author":"Hulthe","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.10.004_bb0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1194\/jlr.M600361-JLR200","article-title":"Relationship of IgM and IgG autoantibodies to oxidized low density lipoprotein and apolipoprotein B100-immune complexes with angiographically determined coronary artery disease and cardiovascular events","volume":"48","author":"Tsimikas","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.10.004_bb0115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/cs1010523","article-title":"Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women","volume":"101","author":"Dotevall","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cca.2011.10.004_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/HAB-2009-0202","article-title":"Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease","volume":"18","author":"Soto","year":"2009","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.cca.2011.10.004_bb0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.10.017","article-title":"Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension","volume":"188","author":"Su","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.10.004_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/clin.1995.1069","article-title":"Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein","volume":"75","author":"Virella","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cca.2011.10.004_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.atherosclerosis.2010.11.024","article-title":"OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells","volume":"214","author":"Lappalainen","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.10.004_bb0140","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/0003319710366124","article-title":"The role of immune complexes in atherogenesis","volume":"61","author":"Burut","year":"2010","journal-title":"Angiology"},{"key":"10.1016\/j.cca.2011.10.004_bb0145","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1161\/01.CIR.102.21.2576","article-title":"Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction","volume":"102","author":"Mustafa","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2011.10.004_bb0150","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.atherosclerosis.2010.11.012","article-title":"Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes","volume":"214","author":"Lopes-Virella","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.10.004_bb0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2006.02.007","article-title":"Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima\u2013media thickness in patients with type 1 diabetes","volume":"190","author":"Lopes-Virella","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.10.004_bb0160","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.cca.2011.05.034","article-title":"Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients","volume":"412","author":"Lobo","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.10.004_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2005.07.023","article-title":"Present and future of the autoimmunity laboratory","volume":"365","author":"Gonz\u00e1lez-Buitrago","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.10.004_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/clim.2002.5269","article-title":"Pro-atherogenic and pro-inflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL","volume":"105","author":"Virella","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cca.2011.10.004_bb0175","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4049\/jimmunol.111.4.1219","article-title":"Detection of antibodies and soluble antigen\u2013antibody complexes by precipitation with polyethylene glycol","volume":"111","author":"Creighton","year":"1973","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2011.10.004_bb0180","first-page":"117","article-title":"Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC)","volume":"36","author":"Harkiss","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2011.10.004_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-8981(95)06054-H","article-title":"Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease","volume":"238","author":"Boullier","year":"1995","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.10.004_bb0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0009-8981(02)00342-X","article-title":"Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease","volume":"327","author":"Wang","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.10.004_bb0195","first-page":"499","article-title":"Lipoprotein autoantibodies: measurement and significance","volume":"10","author":"Virella","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cca.2011.10.004_bb0200","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0731-7085(99)00244-7","article-title":"Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective","volume":"21","author":"Findlay","year":"2000","journal-title":"J Pharm Biomed Anal"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111005651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111005651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:00:58Z","timestamp":1762113658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111005651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0009898111005651"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.10.004","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of immunoassays for anti-electronegative LDL autoantibodies and immune complexes","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2011.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}